During its first-quarter earnings report this spring, Philips, the health technology company, announced it agreed to pay $1.1 billion in a settlement over respiration and sleep apnea machines. This is the latest action over the machines, which were recalled in 2021.
The 2021 recall was mostly around DreamStation CPAP machines due to problems with "sound abatement foam" used in them, per the company's recall letter. The foam "may degrade into particles which may enter the device's air pathway and be ingested or inhaled by the user," and "may off-gas certain chemicals," according to the letter.
